‌

US Patent 11891432 Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods of use

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Laurent Renia0

Zenjiro Sampei0

Cheng-I Wang0

Xing'er Christine Xoo0

Lisa Fong Poh Ng0

Katja Fink0

Date of Patent

February 6, 2024

0

Patent Application Number

169806110

Date Filed

March 15, 2019

0

Patent Citations

US Patent 7282568 Human monoclonal antibodies against interleukin 8 (IL-8)

0

US Patent 9688762 Modified antibody constant region

0

US Patent 9701759 Heterodimeric proteins

0

US Patent 9969800 IL-8 antibodies

0

US Patent 10066018 Antibody constant region variant

0

US Patent 10150808 Modified antibody constant regions

0

US Patent 10253091 Antibody constant region variant

0

US Patent 10421804 Anti-Zika virus antibodies and methods of use

0

...

Patent Primary Examiner

Michael Szperka

0

Patent abstract

The disclosure provides anti-DENV antibodies having a cross-reactivity to ZIKV and methods of making and using the same. The anti-DENV antibodies have uses that include treating or preventing ZIKV infection.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11891432 Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.